CRISPR-Induced Distributed Immunity in Microbial Populations by Childs, Lauren M. et al.
 
CRISPR-Induced Distributed Immunity in Microbial Populations
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Childs, Lauren M., Whitney E. England, Mark J. Young, Joshua S.
Weitz, and Rachel J. Whitaker. 2014. “CRISPR-Induced
Distributed Immunity in Microbial Populations.” PLoS ONE 9 (7):
e101710. doi:10.1371/journal.pone.0101710.
http://dx.doi.org/10.1371/journal.pone.0101710.
Published Version doi:10.1371/journal.pone.0101710
Accessed February 16, 2015 3:32:17 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:12717416
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAACRISPR-Induced Distributed Immunity in Microbial
Populations
Lauren M. Childs
1., Whitney E. England
2., Mark J. Young
3, Joshua S. Weitz
4*, Rachel J. Whitaker
5*
1Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America,
2Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America, 3Thermal Biology Institute and Department of Plant
Sciences and Plant Pathology, Montana State University, Montana, United States of America, 4School of Biology and School of Physics, Georgia Institute of Technology,
Atlanta, Georgia, United States of America, 5Department of Microbiology and Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois,
United States of America
Abstract
In bacteria and archaea, viruses are the primary infectious agents, acting as virulent, often deadly pathogens. A form of
adaptive immune defense known as CRISPR-Cas enables microbial cells to acquire immunity to viral pathogens by
recognizing specific sequences encoded in viral genomes. The unique biology of this system results in evolutionary
dynamics of host and viral diversity that cannot be fully explained by the traditional models used to describe microbe-virus
coevolutionary dynamics. Here, we show how the CRISPR-mediated adaptive immune response of hosts to invading viruses
facilitates the emergence of an evolutionary mode we call distributed immunity - the coexistence of multiple, equally-fit
immune alleles among individuals in a microbial population. We use an eco-evolutionary modeling framework to quantify
distributed immunity and demonstrate how it emerges and fluctuates in multi-strain communities of hosts and viruses as a
consequence of CRISPR-induced coevolution under conditions of low viral mutation and high relative numbers of viral
protospacers. We demonstrate that distributed immunity promotes sustained diversity and stability in host communities
and decreased viral population density that can lead to viral extinction. We analyze sequence diversity of experimentally
coevolving populations of Streptococcus thermophilus and their viruses where CRISPR-Cas is active, and find the rapid
emergence of distributed immunity in the host population, demonstrating the importance of this emergent phenomenon
in evolving microbial communities.
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Introduction
All organisms are susceptible to infection by viral pathogens.
The sheer number of viruses found in natural environments is
staggering; it is estimated that 10
31 virus particles are circulating at
any time [1,2] containing at least hundreds of thousands of
genotypes [3], most of which infect bacteria and archaea. Bacteria
and archaea resist infection through random mutation resulting in
loss or modification of viral receptors, or through targeted defense
systems such as physical blocking, restriction-modification systems,
and abortive infection systems [4–10]. Both negative frequency-
dependent selection (NFDS) and diversifying selection for micro-
bial resistance have been suggested to result in the diversity
observed in natural systems [11–13]. The trade-off between
resistance and growth rate has become the dominant model for
microbe-virus coevolution [14], with variation in fitness driving
diversification of the host and resulting in the predicted
coexistence of many genotypes of both hosts and viruses [15].
These theoretically predicted trade-offs have also been seen to
promote diversity of both host and viral populations in experi-
mentally evolved populations [16–21].
Recently the CRISPR-Cas system was experimentally shown to
function as an adaptive microbial resistance mechanism, using the
model organism Streptococcus thermophilus [22] (see reviews in [6,23–
32]). The CRISPR-Cas system, components of which are found in
the majority of sequenced microbes [33], is comprised of short
DNA fragments (spacers) flanked by palindromic repeats in repeat-
spacer arrays [32]. These fragments are often identical to
sequences in plasmids, viruses, and other foreign elements [34].
When a microbe containing an active CRISPR system encounters
one of these foreign elements, it can add a new spacer matching a
sequence in the foreign genome (protospacer) [22]. The CRISPR
system can acquire spacers from many locations in a foreign
genome, requiring only a short protospacer-associated motif
(PAM) adjacent to the protospacer [25,35]. Repeat-spacer arrays
are transcribed, processed, and used to guide an effector complex
which inactivates matched foreign genetic material on any
subsequent encounter [36]. Escape mutations in protospacers
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coevolutionary dynamic in which viruses evolve through random
mutation while hosts evolve through ‘‘directed mutation’’ facili-
tated by adaptive immunity [25,37–39].
We propose that crucial elements of the CRISPR system result
in a diversifying coevolutionary mode that is distinct from the
traditional trade-off model described above. Adaptive CRISPR
acquisition of new spacers leads to the potential for competing
CRISPR genotypes to emerge within a host population at the
same (or similar) time – akin to the phenomena of ‘‘clonal
interference’’ [40,41]. The vast reservoir of protospacers in each
virus creates the potential for competing host genotypes with
similar (or identical) resistance phenotypes that are not necessarily
subject to fitness tradeoffs between immune alleles. In contrast,
viral strains are limited in potential escape mutations by fitness
constraints on mutations in their genomes that can modify
regulatory elements and RNA- and protein-encoding genes. In
addition, each viral escape mutant only allows access to a single
host immune allele potentially composing a small subset of the host
population [42,43]. We hypothesized that these differences would
allow for a dramatic restructuring of the coevolutionary mode
wherein many different hosts are immune to the same virus in
different ways. We label this many-to-one, genotype-to-phenotype
phenomenon distributed immunity.
We previously developed an eco-evolutionary model of
CRISPR-mediated host-viral coevolution [44]. In brief, the model
incorporates density-dependent Lotka-Volterra like ecological
dynamics with the evolutionary introduction of new hosts and
viral strains with novel genetic states. Ecological rules of
interaction including host reproduction and death, viral infection
of hosts and viral deactivation outside of hosts determine host and
viral densities. Viral infection of hosts can lead to either host lysis
or viral deactivation, which may occur with or without spacer
integration. During replication, viral strains evolve through
mutation generating a novel protospacer. Host immunity is
determined by the presence of at least one spacer matching a
virus, yet is not full-proof, i.e., there is a small chance that a host
with a matching spacer to an infecting virus will not be immune
[44]. In simulations of our model, host and viral populations
oscillate in abundance over short time scales, whereas host and
viral genotype composition changes over long time scales,
mediated by coevolutionary adaptation. A comparison of this
and other models of CRISPR-mediated coevolutionary dynamics
(e.g., [45–49]), whose exact dynamics depend on the specific
molecular, ecological and evolutionary parameters can be found
elsewhere [44,50].
Within our model, examining the diversity of the host
population at each maximum in total host population abundance
(host peaks), we observed two types of emergent population
dynamics: (i) near selective sweeps by novel or recurring strains
and (ii) simultaneous growth of phenotypically similar but
genotypically diverse groups of strains which we termed coalitions
[44]. Although the diversification of host populations with
CRISPR immunity had been noted previously [44,45,48,49,51],
in this paper, we present a metric, population-wide distributed immunity
(PDI) to quantify distributed immunity in a population, to examine
how distributed immunity varies over time and to determine how
this evolutionary mode affects the coevolutionary dynamic. We
used simulated data from our model to: (i) determine when
coalitions are characterized by distributed immunity; (ii) identify
conditions under which distributed immunity is the dominant
evolutionary mode in a simulation; and (iii) quantify the effects of
distributed immunity on host-viral relationships by examining
diversity and stability of host and viral populations. Finally we
determined that the diversity exhibited in an experimental host-
viral community is associated with distributed immunity.
Results
Quantifying distributed immunity
Distributed immunity denotes the emergent phenomenon in which
multiple immune alleles coexist within and between hosts. When
these alleles are distributed between different hosts that have
CRISPR-Cas resistance, then multiple hosts have similar immune
phenotypes yet have distinct, coexisting associated CRISPR
genotypes. To measure the impact of distributed immunity, on
each population, we developed a metric called population-wide
distributed immunity (PDI) in which CRISPR-Cas immune
relationships of all host-host-viral strain triplets are tested to
determine if the two host strains contain spacers matching
different protospacers on the same viral strain (Figure 1, see
Methods for details of the calculation). The intuition behind our
metric is that all triplets contribute positively to PDI when both
hosts are immune to the virus by means of distinct spacers
matching the virus. In the case where both hosts are immune to
the virus but via the identical spacer, the immunity is not
distributed throughout the population and thus does not
contribute to PDI. Although phenotypically immunity via identical
or distinct spacers is equivalent, the varied genotypes may follow
different evolutionary pathways. For example, when PDI is high,
mutation of a single protospacer does not permit escape in the
majority of the host population. However, when PDI is low, a
single protospacer mutation may lead to viral escape in most of the
host population. The degree of contribution by each triplet
depends on the product of the relative abundance of the host
strains and viral strain and immunity between the host and viral
strains (see Methods for details of the calculation). The maximum
PDI for a population at any time increases with the number of host
strains (with n host strains the maximum is 1-1/n) and is only
obtainable when the following hold: there are at least two alleles
that confer immunity to the viral strains, all host strains are
immune to viral strains, and the abundance of each host CRISPR
allele is equal (Figure S1). Note that the abundance of the viral
strains does not affect the potential for PDI (see SI text for further
discussion).
In the simulated eco-evolutionary dynamics of hosts and viruses
[44], we find that PDI varies through time (Figure 2). PDI is
typically highest just prior to peaks in host population density and
drops to at or near zero in between (Figure 2). Every peak of host
density does not contain high PDI, even if its potential maximum
PDI is high, and in our simulations we find that measured PDI is
well below the potential maximum. Low PDI results from (i)
unevenness of the host population (Figure 2b-1, Figure S1), (ii) a
large fraction of the hosts lacking immunity to the viral population
(Figure 2b-2) or (iii) the majority of hosts having immunity to the
viral population via the same spacer (Figure 2b-4). In contrast,
high PDI occurs when multiple hosts have unique spacers to the
same viral strains. This can occur when a dominant host strain
diversifies via the acquisition of unique spacers to the same viral
strain (Figure 2b-3). Across all simulations, the PDI at host peaks
ranges from 0 to 0.7203 with an overall mean of 0.0710. We find
no direct, predictable relationship between the abundance of host
and viral populations at their peaks in relation to the concurrent
value of PDI within a single simulation. In contrast, we
hypothesize that PDI functions to alter the future host and viral
dynamics within a community. Diversified hosts (with a high PDI)
may affect the composition and total density of virus populations
that recur in the next peak in host density or much later. This is
CRISPR-Induced Distributed Immunity in Microbial Populations
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populations in which a particular diversified host can be targeted
by divergent low abundance viruses that were created much
earlier.
Parameters that increase population-wide distributed
immunity
To determine how biological parameters might influence the
evolutionary mode across a simulation toward or away from
distributed immunity, we altered four parameters that vary
between microbial and viral strains: viral mutation rate, m; spacer
acquisition rate, q; maximum host spacer number, S; and viral
protospacer number, P. To avoid the period of transient dynamics
occurring at the initiation of the simulations from a single viral and
single host strain, we measure median PDI in the last 500 hours of
each simulation, where the host spacer locus is filled and both host
and viral diversity are most regular (see File S1, Figure S2).
Comparing the population dynamics between sets of simulations
with varying parameters, we found that average PDI across the
simulations increases when viral mutation rate decreases and when
the number of relative protospacers increases (Figure 3). There are
also increases in PDI when the spacer acquisition rate increases
and the number of spacers increases, but PDI above 0.1 is rarely
seen (Figure 3). The highest average PDI is seen with high relative
protospacer number (P=20) and low viral mutation rate
(m=10
27) while lowest average PDI occurs with low relative
protospacer number (P=5) and low spacer acquisition rate
(q=10
26). Increases in average PDI result from coevolutionary
dynamics that include more host population peaks with higher
PDI, rather than from an increase in PDI when host populations
are not near their peak values.
Population-wide distributed immunity is associated with
individual distributed immunity
In simulations with a higher average PDI, we observed an
additional dynamic where individual host genotypes contain
multiple spacers matching the same viral strain at distinct
protospacers. This represents an analogous form of distributed
immunity, albeit within a single host. Since this will have similar
evolutionary effects as PDI, we quantify the average per host
immunity to viral strains with a new metric denoted as individual
distributed immunity (IDI). IDI is equal to the average number of
distinct matching spacers between each pair of viral and host
strains (see Methods for details of the calculation). When IDI is
greater than one, the host population is on average immune in
multiple ways to the viral population due to targeting multiple
regions of the viral genome. We find that there is strong
correlation between PDI and IDI (Figure S3) and, as with PDI,
there is high IDI with low viral mutation rate and high protospacer
number (Figure S4). Hereafter, we collectively refer to PDI and
IDI as DI.
Elevated distributed immunity is associated with
increases in host diversity, density, and stability
Having identified conditions under which simulations with high
levels of distributed immunity are linked to changes in host-virus
relationships, we investigated possible consequences of these
altered interactions. We found that simulations resulting in high
levels of distributed immunity are correlated with increased host
strain count and population density (Figure 4A–D). We find a
much stronger association between DI and these population level
indicators than when evaluating the statistical relationship between
mutation rate and protospacer number alone. For example, the
Spearman rank correlation coefficient between host population
density and PDI is 0.84 whereas it is 20.31 and 0.49, when
evaluated against mutation rate and P, respectively (all p,0.001).
Similarly, the Spearman rank correlation coefficient between host
strain count and PDI is 0.78 whereas it is 20.26 and 0.27, when
evaluated against mutation rate and P, respectively (all p,0.001).
The data collapse of host population density and host strain count
as a function of PDI from simulations with different governing
parameters is apparent in Figure 4A–D. Investigating simulations
where distributed immunity has a strong effect (high DI), we also
observed extended periods of high density, stable host populations
(see time points between 9700–10000 in Figure 5A–C for a typical
example). Periods of stable host-controlled dynamics occur
exclusively in parameter sets which have higher DI: P=15,
P=20, and m=10
27, and the proportion of simulations which
exhibit extended stable periods increases with increasing DI
(Figure 5E, black bars). The finding of extended stability is not
driven solely by the extended high host density; this pattern is
observed whether DI is measured at all time points (as in
Figure 5E), or only at host density peaks.
Figure 1. Population distributed immunity (PDI) depends on immunity relationships between hosts (circles) and viruses
(hexagons). Immune elements are denoted as linear arrays of boxes. PDI is the sum of contributions (dPDI) calculated amongst triplets of two hosts
and one virus, adjusted by their population proportions, as follows: (A) dPDI=0 when only one (or neither) hosts in a triplet match the virus as
R(N1,V1)=M(N1,V1)=0, R(N1,V1)=M(N1,V1)=1,and R(N1,N2,V1)=0. (B) dPDI=0 when both hosts match the virus with the same spacer as
R(N1,V1)=M(N1,V1)=1, R(N1,V1)=M(N1,V1)=1,and R(N1,N2,V1)=0. (C) dPDI=N1N2V1{1-[|N1-N2|/max(N1,N2)]} when both hosts match the virus via
different spacers ass R(N1,V1)=M(N1,V1)=1, R(N1,V1)=M(N1,V1)=1,and R(N1,N2,V1)=1. Identical colors, indicated by arrows, represent matching spacer-
protospacer pairs. White protospacers and spacers are unique.
doi:10.1371/journal.pone.0101710.g001
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and density
In contrast to the increases in host population density and host
strain count as PDI increases, the trends for viral population
density and viral strain count are non-monotonic (Figure 4E–H
and Figure S5). At lower PDI (PDI,0.2) increases in PDI correlate
with increases in viral population density and weakly correlate
with increases in viral strain count (Figure 4 and Figure S5). The
observed viral population increases are also correlated with
increases in host population size and host immunity (Figure S6).
Although immunity is increasing, it is still relatively low, suggesting
that individual viral strains can continue to grow on subsets of the
total host population. Simultaneously, as PDI increases, the host
population is also increasing, so that each subset of hosts that
viruses can infect is actually larger than at lower PDI. At higher
PDI (PDI.0.2), increases in PDI correlate with decreases in viral
population density and viral strain count (Figure 4). Beyond
PDI=0.2, increases in host population size and immunity no
Figure 2. Host populations exhibit periods of different coevolutionary dynamics. (A) Population dynamics of the host (top) and virus
(middle) and PDI (bottom) from a representative simulation. Each color represents a host or viral strain with a unique spacer or protospacer set and is
proportional in height to the strain proportion in the population; colors repeat when not touching. (B) Spacer-protospacer matches between major
host and viral strains at four time points as examples of single-strain dominance (1), coalitions with low immunity (2), coalitions with high PDI (3), and
coalitions with high immunity but low PDI (4). The spacer and protospacer composition of each host or viral strain, respectively, is listed horizontally.
The number in the first column indicates the proportion of each strain in the population, while the remaining boxes represent the spacer or
protospacer state. Host strains making up less than 2% and viral strains making up less than 5% of the population, which only have minor impact on
the calculated PDI, are omitted for space. Matching colors in host and viral boxes indicate a spacer-protospacer match. White boxes are spacers or
protospacers without a match. Model parameters are standard parameters in Table S2.
doi:10.1371/journal.pone.0101710.g002
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density is consistent with the fact that the proportion of hosts that
viruses can infect (HVI, see Methods for details of the calculation)
decreases as DI increases, and HVI is significantly lower in
simulations with higher DI (Figure S7). Accompanying decreases
in viral population sizes we find that the proportion of simulations
in which viruses go extinct increases with increasing DI (Table S1
and Figure 6, dark gray bars). Parameter sets with the highest DI,
P=20 and m=10
27, result in viral extinction in 10% and 12% of
simulations with filled loci, respectively, the highest rates of
extinction of any parameter set (Table S1). Considering simula-
tions in which the CRISPR locus does not fill before the last
500 hours, 90.7% end in viral extinction, including 94.3% and
91.6% of P=20 and m=10
27 simulations, respectively. Nearly all
simulations with lower DI reach a full spacer locus prior to the
final 500 hours (Table S1).
Elevated distributed immunity identified in an
experimental viral-host community
We examined whether the dynamic of distributed immunity
observed in simulations is consistent with patterns observed in
experimental microbial communities in which both virus and host
sequence is known. To do so, we estimated DI within an
experimental set of host and viral populations. A quantitative
assessment of the contribution of the relative DI to the
maintenance of diversity in natural microbial populations is not
possible in most studies, as the contemporary virus population is
not typically sequenced. Despite technical challenges to date in
testing distributed immunity in natural populations, studies in
laboratory populations offer an opportunity to measure distributed
immunity. Numerous studies in laboratory populations have
shown that upon challenge by a single phage, multiple S.
thermophilus genotypes emerge with different spacers providing
immunity [22,25,26,37,38,52]. For our analysis, we used data
from Sun et al. [38], the only study with both sequences and
abundances from the entire coevolving host and viral populations
as required to measure DI. In this study, a laboratory-coevolved
population of Streptococcus thermophilus and its phage 2972 was found
to exhibit rapid spacer addition as well as phage CRISPR escape
mutations. After 1 week of co-culture, the host had added 43 new
spacers to one CRISPR locus, and three viral mutations in
targeted protospacers or PAMs were detected [38]. Given the
diversity of new spacers matching a small pool of viral types, we
estimated a high value of PDI for these populations. Using
populations reconstructed from spacer-containing reads and viral
SNP distributions (Figure 6, see Methods), the value of PDI after 1
week of coevolution was 0.4331, out of a maximum possible PDI
of 0.5933. This estimate of elevated PDI complements Sun et al.’s
[38] observation of multiple acquisitions of distinct CRISPR
escape mutants, and suggests a population-level effect that may act
synergistically with individual host-viral interactions. Note that this
PDI value is larger than the median PDI in 99.8% and the highest
observed PDI in 75.9% of all simulations we conducted. The value
of IDI, 1.2264, was higher than the median IDI in 97.7% and the
highest observed IDI in 58.7% of simulations.
Figure 3. PDI is elevated at high protospacer number and low viral mutation rate. Measured PDI in numerical simulations is shown with
varying (A) protospacer number; (B) host acquisition rate; (C) viral mutation rate; (D) spacer number. Bars (and lines) represent mean (and SEM) of PDI
of replicate simulations, with each replicate represented by the median value across the final 500 hours of that single simulation. Unless varied,
parameters are S=10, P=10, q=10
25, m=5 610
27. Using analysis of variation for unbalanced data all pairwise comparisons of mean PDI are
significant at p,0.001 except comparisons between: m=5 610
27 and m=7.5610
27 (p,0.01) in (C); m=7.5610
27 and m=10
26 (not significant) in (C);
and q=5610
25 and q=10
24 (not significant) in (D).
doi:10.1371/journal.pone.0101710.g003
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We have explored the immune dynamics resulting from a
computational eco-evolutionary model driven by CRISPR-medi-
ated immunity. The model demonstrates how a host-viral
community can evolve a complex structure where different hosts
are immune to the same virus as a result of immunity conferred by
Figure 4. PDI and population measures when varying mutation rate and protospacer number. High PDI is associated with (A–B)
increases in host population density, (C–D) increases in host strain count, non-monotonic changes (E–F) in viral population density, and non-
monotonic changes (G–H) in viral strain count. Left column is varying mutation rate, m, and right column is varying protospacer number, P. Unless
varied, parameters are S=10, P=10, q=10
25, m=5 610
27. Each point is the median from the last 500 hours of a single simulation. Note that both
viral population density and viral strain count are unimodally related to PDI, with the lowest levels of both viral population density and strain count
occurring at high PDI. The Spearman rank correlation coefficients of all comparisons, noted in the upper right corner of Figure panels, are significant
at p,0.001. These relationships, including those that are non-monotonic, are discussed further in the main text.
doi:10.1371/journal.pone.0101710.g004
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immunity. Immunity relationships between hosts and viruses with
distributed immunity may appear similar from the phenotype level
to relationships lacking distributed immunity; however, the
underlying genetic diversity present in distributed immunity
changes the dynamics of coevolution. In particular, during periods
of elevated distributed immunity, the host population is diverse
and stable while the viral population is restricted in the number
and extent of possible beneficial mutations and is prone to
extinction. The stable maintenance of multiple non-dominant
genotypes that accompanies distributed immunity is likely
facilitated by NFDS. The generation of distributed immunity
and the selective mechanisms of NFDS may work together to
promote diversity.
Several CRISPR models have previously observed diversity in
host spacer content both at an individual and population level
[44,45,48,49], but understanding that diversity has been a recent
exploration. Although Iranzo et al. [49] established several
population-level findings, such as CRISPR immunity promoting
the coexistence of viruses and hosts at intermediate viral mutation
rate and the lack of increased viral diversity with CRISPR
immunity, they did not attempt to expound upon these findings,
which they labeled counterintuitive. Our model, even with its
reduced complexity as we ignore populations lacking CRISPRs, is
able to reproduce these results and offer an explanation for them
via distributed immunity. Here, we have demonstrated that the
consequences of viral protospacer number and mutation rate as
well as host spacer acquisition rate and spacer number on the
Figure 5. Host stability in a high DI population. (A) Plot of host dynamics for a representative model simulation containing an extended period
of host population stability. Each color represents a host strain with a unique spacer set and color height is equal to population proportion of the
strain; colors repeat when not touching. (B) Total population density in log-scale of host (blue) and virus (red) strains. (C) PDI (magenta, left y-axis) and
IDI (green, right y-axis) metrics. (D) Spacer-protospacer matches at 9800 hours. The spacer and protospacer composition of each host or viral strain,
respectively, is listed horizontally. The number in the first column indicates the proportion of each strain in the population, while the remaining boxes
represent the spacer or protospacer state. Strains making up less than 5% of the population are omitted for clarity. (E) Numbers at the top of each bar
designate the total number of simulations in each bin. A simulation is denoted as ‘‘stable’’ when the host population remains above 3e5 (close to
carrying capacity) for at least 100 consecutive hours, and as ‘‘viral extinction’’ if the simulation ends prior to the designated endpoint due to reaching
a viral population size below our density cutoff of 0.1/mL. Comparisons of subsampled data for stable and viral extinction show significant differences
between means of all PDI bins (except between 0–0.1 and 0.1–0.2 stable simulations) and all IDI bins (except between1.8–2.4 and 2.4–3.0 stable
simulations).
doi:10.1371/journal.pone.0101710.g005
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distributed immunity thereby linking the molecular and evolu-
tionary mechanisms to the eco-evolutionary dynamics that have
been observed. Since distributed immunity only requires some of
the spacers to be distinct, it is consistent with a previously posed
model where random deletion lead to selective sweeps of trailer-
end spacers [48].
CRISPR-Cas diversity varies greatly among systems. At one
end of the spectrum are the slowly-evolving CRISPR-Cas systems
of Escherichia and Salmonella, where estimates indicate that strains
that have diverged in the last thousand years have identical
CRISPR loci [53]. At the other end are natural populations
exhibiting high CRISPR-Cas diversity, including the human gut
microbiome [54], Yersinia pestis plague foci [55], and hot spring
populations of Sulfolobus islandicus [56,57]. Notably, in the case of S.
islandicus, these archaeal populations do not contain a dominant
genotype or display evidence of selective sweeps over a ten-year
interval [57] but maintain diversity at both the leader and trailer
ends of the CRISPR loci over time. Some natural populations
demonstrate evidence of past selective sweeps in the form of
conserved trailer-end spacers, particularly populations of acido-
philic microbes found in acid mine drainage [48,58,59]. The
difference between the immune structures of different microbial
populations may be driven by differences in the extent of
distributed immunity within populations, differences in the levels
of reassortment of CRISPR alleles between strains in different
populations [57], or the action of other host defense systems
operating along with CRISPR-Cas immunity.
Indeed, our model suggests that the biology of CRISPR-Cas
system might define the resulting level of diversity observed in
natural populations. We show that the number of protospacers,
viral mutation rate, and host acquisition rate all significantly
influence the level of distributed immunity in a way that would
result in different immune structures in natural populations. These
factors have been shown to vary in natural microbial populations.
For example, in microbes with active CRISPR-Cas defense, the
number of protospacers is determined by both the length of the
viral genome and the length and sequence of the PAM sequences,
which direct acquisition and interference. We infer that proto-
spacer number is positively correlated with distributed immunity
because at higher protospacer numbers it is easier for hosts to
acquire multiple spacers to the same virus (higher IDI) and for
different hosts to acquire different spacers (higher PDI). We
hypothesize that microbial hosts utilizing shorter PAMs or that are
infected by viruses with larger genomes are more likely to display a
diversified immune structure that is consistent with distributed
immunity. Variation in viral mutations rates has also been
observed in natural populations. For example, it has been
suggested that thermophiles and their viruses have lower mutation
rates than their mesophilic counterparts [60,61]. Our model
suggests that this is consistent with data showing that the
thermophilic archaeon S. islandicus appears to maintain a stable
diversified population over time [56,57]; however, this hypothesis
must be explicitly tested. Finally, in this study we did not explore
variation in the probability that CRISPR immunity fails such that
a host cell does not recognize and clear a virus for which it has a
matching spacer. Such failure may result in the proliferation of a
virus to which there exists some immunity in the population.
Given our previous analysis showing the relatively minor effects of
such failure on resulting dynamics [44], we do not expect
significant effects of the stochastic failure of host spacers on
distributed immunity, at least in the range of failure values
observed experimentally [22]. However, in the case of exposure to
plasmids rather than viruses, such failure may permit the exchange
of genetic material between hosts [62]. Under conditions when
genetic exchange is advantageous (e.g., in the presence of many
beneficial plasmids [63]) then the occurrence of distributed
immunity may result, even if seemingly unfavorable, to protect
against virulent viruses.
Although natural population data is not yet available to employ
our novel metrics PDI and IDI for quantifying distributed
immunity, we have quantified this evolutionary mode in an
experimental population. Qualitatively, Sun et al. [38] observed
rapid transition from clonal to diversified in both host and viral
populations as a result of CRISPR-Cas immunity. We demon-
strated that this diversification also exhibited rapid emergence of
DI and hypothesize that our finding of highly elevated PDI in Sun
et al. [38] may be due, in part, to the relatively large number of
protospacers in the genomes of phage (associated with replete
PAMs), as compared to the use of low number of protospacers
(P=5–20) in our models due to computational constraints. This
hypothesis is further supported by our simulation results where DI
increases as we increase protospacer number (see Figure 3A). We
predict that in this system when the S. thermophilus hosts exhibit
distributed immunity, viral populations will be smaller, less diverse
and more prone to extinction. We consider it an important future
goal to extend the DI analysis of S. thermophilus and phage to
systems in which host and viral metagenomes are available to
further quantify the variation of DI in natural populations.
A better understanding of CRISPR-mediated coevolutionary
dynamics will have important implications for medical applica-
tions for example those seeking to target microbial pathogens with
phage therapy. In addition, our model suggests possible optimal
strategies for engineering stable microbial communities immune to
phage attack such as those used in biofuels production or other
industrial applications. Finally, CRISPR immunity serves as an
interesting model system in which to study the broader effects of
Figure 6. PDI and IDI estimated in a population of Streptococcus
thermophilus and its phage 2972. Data from [38] (accession number
SRA049615). Virus protospacer and host spacer states are shown after
one week of experimental coevolution. Matching colors in host and
viral boxes indicate a spacer-protospacer match. White boxes are
spacers or protospacers without a match. All viruses are shown; host
strains that make up less than 3% of the population are not shown for
clarity. Protospacer positions for which there is no match between any
virus and the hosts shown are omitted.
doi:10.1371/journal.pone.0101710.g006
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impacts the trajectory of host-virus coevolution in microbes
mediated by CRISPR-Cas immunity. Further understanding
how distributed immunity affects the evolutionary path of
populations may yield insight into the effects of host immune
diversity in microbial communities and other systems.
Methods
Model information and statistical analyses
We use the model introduced in Childs et al. [44] to generate
our simulation data. Briefly, in the model, ecological host-viral
dynamics are combined with the introduction of new host and
viral strains through changes in the CRISPR space and
protospacer states. Hosts may acquire new spacers during viral
infection, and viruses may mutate to novel protospacers during
replication. Host immunity towards an infecting virus requires the
presence of at least one spacer matching a viral protospacer, but is
not full proof. The population dynamics of host and viral strains
are deterministic but the incorporation of hosts’ spacers and
mutation of viral protospacers occurs stochastically. Further details
of the model are reviewed in the supplemental information with
the parameters used in Table S2. Although this paper focuses on
four parameters (protospacer number, spacer number, viral
mutation rate, spacer acquisition rate), Childs et al. [44] more
thoroughly tests dependencies of model dynamics on other
parameters. Due to the stochastic nature of our model, the
parameter regions surveyed were limited by computational cost.
All results presented are averages of 200 replicate simulations,
unless otherwise noted (Table S1), with each replicate represented
by the median value across the final 500 hours of that simulation.
One hour is equivalent to the inverse of the growth rate – what we
denote here as a typical host generation time. Simulations were
excluded from population averages whenever the spacer states did
not contain the maximum number of spacers (full locus)
throughout the final 500 hours of simulation or whenever the
viral population fell below our density cutoff before the locus was
filled (Table S1).
For each of the four parameters varied (protospacer number,
spacer number, viral mutation rate, spacer acquisition rate),
measurements from replicates at each parameter value tested were
grouped. The means of replicate PDI and IDI measurements were
compared using analysis of variation for unbalanced data (data
from Figure 3 and Figure S4).
The Spearman rank correlation coefficients were determined
for variations in each parameter between PDI, host population
density, viral population density, host strain count, viral strain
count, and IDI (data from Figure 3, Figure S3 and Figure S5). The
Spearman rank correlation coefficients were also determined for
variations in PDI, host population density and immunity
combining all parameter sets (data from Figure S6). R
2 values
were determined for correlations between HVI and PDI, and
between HVI and IDI (data from Figure S7).
The data collapse of host and viral output variables, as a
function of PDI, from simulations with different governing
parameters is apparent in Figures 4 and Figure S5. To test for
correlations, linear R
2 values were determined for variations in
each parameter between PDI, host population density, viral
population density, host strain count, viral strain count and IDI for
variations in each parameter (data from Figure 4, Figure S5).
Despite significant linear correlation in almost all cases, except
between PDI, host strain count and viral strain count when
varying S, it was evident upon inspection that the relationships
between PDI and viral population density and viral strain count
were better described by non-linear functions, particularly
quadratic functions. To quantify this, we fit a quadratic model
for viral output parameters and compared the quality of fit to a
linear model using AIC; the relationship of all PDI and viral
output statistics were better fits as demonstrated by lower AIC
values except for PDI and viral strain count when varying S where
both linear and quadratic fits were not significant (See Table S3).
To compare the proportion of simulations that are stable,
fluctuating, or end in viral extinction, 10,000 random subsamples
of 230 simulations (10% of the total simulations with filled loci)
were taken. The mean proportions of simulations in each bin that
fell into the stable or viral extinction category were compared
using analysis of variation (data from Figure 6). We define a
population to be stable when the host population exceeds 3e5 for
more than 100 hours (approximately 95% of the carrying
capacity).
Population-wide distributed immunity (PDI)
To quantify the population-level distribution of immune alleles
between hosts with similar immune phenotypes but distinct
CRISPR genotypes, we compare all triplets of two host strains
and a viral strain. We determine which triplets contain distinct
spacers matching protospacers in the virus to quantify PDI as
follows:
PDI~
X
i
X
j
X
k
1{
DNi {Nj D
max(N)
  
sijk Ni Nj Vk
sijk ~
1, if R(Gi ,Hk )R(Gj ,Hk )wR
2
(Gi ,Gj ,Hk )
0, otherwise
8
<
:
where Ni is the population proportion of the i
th host strain, Vk is the
population proportion of the k
th viral strain, Gi is the set of spacers
belonging to the i
th host strain, Hk is the set of protospacers
belonging to the k
th viral strain, R(Gi,Hk) determines the number of
matching spacers and protospacers between the states Gi and Hk,
and R(Gi,Gj,Hk) determines the number of matching spacers and
protospacers between all the states Gi, Gj and Hk. Further, max(N)
denotes the maximum proportion of any given host strain in the
population.
Triplets with matching spacers and protospacers contribute to
PDI via the function s. The relative of abundance of the strains
from a triplet determines the level of contribution of that triplet to
PDI. The total value of PDI is weighted by host strains at or
similar to the size of the dominant host strain in order to minimize
the summed contribution of numerous strains found at low
proportion.
Individual distributed immunity (IDI)
We introduce individual distribution immunity to quantify the
distribution of immunity within hosts, in contrast to PDI, which
quantifies the distribution of immunity between hosts. IDI is the
average number of spacers per host matching the viral population:
IDI~
X
i
X
k
Ni Vk R(Gi ,Hk)
where the host proportion (Ni), the viral proportion (Vk), the host
spacer state (Gi), the viral spacer state (Hk), and the number of
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defined as in PDI.
Hosts that Viruses can Infect (HVI)
The average proportion of hosts that viruses can infect is
quantified by HVI:
HVI~
X
i
X
k
Ni Vk 1{M (Gi ,Hk )
  
where M(Gi,Hk) determines the presence or absence of matching
spacers and protospacers between the states Gi and Hk. The host
proportion (Ni), the viral proportion (Vk), the host spacer state (Gi),
the viral spacer state (Hk) are defined as in PDI.
Experimental population DI calculations
Sequencing reads from the Sun et al. study [38] (accession
number SRA049615) containing at least two novel spacers, or at
least one novel spacer plus ancestral spacers or leader sequence
were considered. Reads were grouped by spacer content; where
trailer-end sequence information was not available, the locus was
assumed to have the same trailer-end spacers as other reads with
similar leader-end spacer content (Figure S8). If trailer end spacers
could not be inferred in this way, the trailer end was assumed to
contain only spacers fixed in the population (Figure S8). Each
unique set of spacers was considered a host strain; the proportion
of reads matching each strain was used for the proportion of each
strain in the population (Ni and Nj) for calculation of PDI and IDI.
Assuming similar CRISPR loci whenever possible maximizes the
number of reads grouped into each CRISPR-type and prevents
overestimation of PDI.
Frequencies of three phage mutations in protospacers or PAMs
identified by Sun et al. [38] were confirmed using breseq
[64](available online at http://barricklab.org/breseq). Each pos-
sible combination of SNPs was considered a different viral strain.
To determine the proportion of phages with each combination of
SNPs (SNP-i only, SNP-i and SNP-ii, SNP-i and SNP-iii, or all
three SNPs), each mutation was considered an independent event
and the probability of each combination was calculated. These
proportions were used for Vk in the PDI and IDI equations.
Otherwise, PDI and IDI were calculated as in simulated
populations.
Supporting Information
Figure S1 Maximum possible PDI changes with the
number of host strains. The maximum attainable PDI is
determined by the number of host strains, the evenness of the host
abundances and requires all host strains are immune to all viral
strains. Maximum PDI increases towards one when all hosts have
equal abundance (blue). When one host dominates, for example
50% of the population (green) or 90% of the population (red), and
all other hosts have equal abundance, the maximum PDI is
significantly reduced.
(EPS)
Figure S2 Early time course of a representative simu-
lation with standard parameters listed in Table S2.
Despite seeding with a single host and viral strain, many strains
rapidly appear as result of the ever-changing immunity structure.
Thick lines at the top of panels A and B are total population
density; thin lines are population density of individual host strains
(blue lines, A) and viral strains (red lines, B). During the initial
hours there is more defined population strain structure when the
average spacers per host is low (C).
(EPS)
Figure S3 PDI is positively correlated with IDI. Each
point is the median from last 500 hours of a single simulation
varying (A) protospacer number, P; (B) spacer number, S; (C) viral
mutation rate, m; (D) host spacer acquisition rate, q. Unless varied,
S=10, P=10, q=10
25, m=5 610
27.R
2 correlation coefficients,
noted in the upper-right corner of figure panels, of all comparisons
are significant at p,0.001. Correlations are depicted with solid
black lines.
(EPS)
Figure S4 IDI varies with: (A) protospacer number; (B)
spacer number; (C) viral mutation rate; (D) spacer
acquisition rate. Unless varied, S=10, P=10, q=10
25,
m=5 610
27. Bars (and lines) are mean (and SEM) of IDI of
replicate simulations, with each replicate represented by the
median value across the last 500 hours. Using analysis of variation
for unbalanced data all pairwise comparisons of mean PDI are
significant at p,0.001 except in (D) where all pairwise comparison
with q.1e-6 (not significant).
(EPS)
Figure S5 PDI and population measures when spacer
acquisition rate and spacer number are varied. PDI is
only weakly correlated, if at all, with host population density (A–
B), host strain count (C–D), viral population density (E–F) and
viral strain count (G–H) across variation in spacer acquisition rate,
q (left column), and spacer number, S (right column). Unless
varied, S=10, P=10, q=10
25, m=5 610
27. Each point repre-
sents the median of the last 500 hours in a single simulation.
Linear R
2 correlation coefficients (A–D) and quadratic R
2
correlation coefficients (E–H), noted in the figure panels, of all
comparisons are significant at p,0.001 except PDI with host
strain count (in D) and PDI with viral strain count (in G) when
spacer acquisition rate is varied. Correlations are depicted with
solid black lines (A–D) and curves (E–H).
(EPS)
Figure S6 Low PDI (,0.2) is correlated with increases
in immunity (A) and host population density (B). At high
PDI (.0.2) immunity (A) and host population density (B) are
uniformly high. Each point represents the median of the last
500 hours of a single simulation; all parameter sets from Table S1
are included. R
2 correlation coefficients (A) 0.59 and (B) 0.78 are
significant at p,0.001.
(EPS)
Figure S7 HVI decreases with increasing PDI (A–C) and
IDI (D–F). PDI values binned by 0.1; IDI values binned by 0.6.
Bars (and lines) are mean (and SEM) of median HVI across the last
500 hours of each replicate simulation from a pool of 100
simulations per parameter set. Parameters for each panel are (A,D)
S=10, P=10, q=10
25, m=5 610
27; (B,E) S=10, P=20,
q=10
25, m=5 610
27; (C,F) S=10, P=10, q=10
25, m=10
27.
All other parameters as listed in Table S2. R
2 values (data not
binned) are noted in each panel with *, p,0.01,;**, p,,0.001;
NS, not significant.
(EPS)
Figure S8 Example of methodology of CRISPR locus
reconstruction from sequencing reads. Each color repre-
sents a unique spacer. Each horizontal row on the left shows the
spacer content of a single read; its corresponding row on the right
shows the inferred complete spacer content. The spacer marked
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fixed in the current population. L, leader sequence; T, spacers
present in ancestral host.
(EPS)
Table S1 Summary of simulated population outcomes.
Summary of the population outcomes (complete, viral extinction,
unfilled locus) of simulations for each parameter set.
(DOCX)
Table S2 Model parameters. Description of parameters
including symbol and value used for simulation of the model.
(DOCX)
Table S3 Linear-quadratic model comparisons. Summa-
ry of the R
2 computation for Figure 4E–H and Figure S5E–H and
choice of model fit using AIC.
(DOCX)
File S1 Supplemental Information. Includes a detailed
description of the model used for simulation; a discussion of how
host and viral strain size and immunity affect PDI; and a
description of transient dynamics of hosts with limited immune
history.
(DOC)
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